Search Within

Computational Oncology Service

  1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (23)
  2. Meeting Abstract (20)
  3. Review (1)
Groups
  1. Department of Medicine (44)
  2. Epidemiology and Biostatistics (44)
  3. GSK Faculty (44)
  4. Melanoma and Immunotherapeutics Service (44)
  5. Solid Tumor Oncology Division (44)
  6. Human Oncology and Pathogenesis Program (35)

More Groups

People
  1. Nikolaus Schultz (23)
  2. Jedd Wolchok (19)
  3. Taha Merghoub (19)
  4. David Solit (17)
  5. Alexander Shoushtari (15)
  6. Francisco Sanchez Vega (12)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (12)
  5. 2021 (4)
  6. 2020 (7)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Cancer Research (4)
  3. Nature (4)
  4. Cancer Cell (3)
  5. Clinical Cancer Research (3)
  6. Journal for ImmunoTherapy of Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (13)
  2. American Association for Cancer Research (7)
  3. Nature Publishing Group (6)
  4. Cell Press (5)
  5. Biomed Central Ltd (3)
  6. Nature Research (3)

More Publishers

Results (44)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
    Journal Article

    Zehir, A.; Benayed, R.; Shah, R. H.; Syed, A.; Middha, S.; Kim, H. R.; Srinivasan, P.; Gao, J.; Chakravarty, D.; Devlin, S. M.; more...
    Nature Medicine (2017)

    Fulltext@MSK | Save
  • Morphological characterization of colorectal cancers in the Cancer Genome Atlas reveals distinct morphology-molecular associations: Clinical and biological implications
    Journal Article

    Shia, J.; Schultz, N.; Kuk, D.; Vakiani, E.; Middha, S.; Segal, N. H.; Hechtman, J. F.; Berger, M. F.; Stadler, Z. K.; Weiser, M. R.; more...
    Modern Pathology (2017)

    Fulltext@MSK | Save
  • Clinical next generation sequencing (NGS) of esophagogastric (EG) adenocarcinomas identifies distinct molecular signatures of response to HER2 inhibition, first-line 5FU/platinum and PD1/CTLA4 blockade
    Meeting Abstract

    Janjigian, Y. Y.; Sanchez-Vega, F.; Jonsson, P.; Tuvy, Y.; Bouvier, N.; Riches, J.; Kundra, R.; Ku, G.; Hechtman, J. F.; Kelsen, D.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence
    Journal Article

    Nissan, M. H.; Pratilas, C. A.; Jones, A. M.; Ramirez, R.; Won, H.; Liu, C.; Tiwari, S.; Kong, L.; Hanrahan, A. J.; Yao, Z.; more...
    Cancer Research (2014)

    Fulltext@MSK | Save